StockData
Arq, Inc. logo

Arq, Inc. (ARQ) stock

ARQNasdaqMiscellaneous Chemical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3038% below fair value
$3.04−0.06 (-1.94%)

Close on Nov 17, 2026Market cap $132.75MP/E –Yield –

Earnings

Arq's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 9, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$38.20M
+8.8% on a year earlier
EPS, Q3 FY2026
$0.06
-$0.02 a year earlier
Latest guidance
Issued
Nov 4, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Arq's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 9, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026after the close$38.20M+8.8%$0.06Release
Q2 FY2026ended Jun 30, 2026Aug 10, 2026during market hours$29.90M+4.5%-$0.02Release
Q1 FY2026ended Mar 31, 2026May 6, 2026during market hours$29.10M+7.0%-$0.02Release
Q4 FY2025ended Dec 31, 2025Mar 10, 2026during market hours$29.40M+8.9%-$1.20Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025during market hours$35.10M+0.9%-$0.02Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025during market hours$28.60M+12.6%-$0.05Release
Q1 FY2025ended Mar 31, 2025May 7, 2025before the open$27.20M+25.3%$0.00Release
Q4 FY2024ended Dec 31, 2024Mar 5, 2025during market hours$27.00M–-$0.03Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open$34.80M+16.8%$0.04Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024during market hours$25.40M+24.5%-$0.06Release
Q1 FY2024ended Mar 31, 2024May 8, 2024during market hours$21.70M+4.3%-$0.09Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Arq's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenueGAAPFY2026$120.00M – $125.00M–NewNov 4, 2026
revenueFY2026$120.00M – $125.00M$120.00M – $125.00MReaffirmedAug 10, 2026
revenueGAAPFY2026$120.00M – $125.00M–NewMar 9, 2026
Adjusted EBITDAnon-GAAPFY2026$19.00M – $20.00M–NewNov 4, 2026
Adjusted EBITDAnon-GAAPFY2026$17.00M – $20.00M$17.00M – $20.00MReaffirmedAug 10, 2026
capexFY2026$8.00M – $10.00M–NewAug 10, 2026
capital expendituresGAAPFY2026$8.00M – $10.00M–NewNov 4, 2026
Additional revenue from other chemicals and productsFY202613% – 15%–NewMar 9, 2026
PAC average selling price (“ASP”)FY2026$1 – $1–NewMar 9, 2026
production volumesFY2026122 – 125–NewMar 9, 2026

Guidance history

Every forecast Arq put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026capital expendituresFY2026$8.00M – $10.00MNew
Nov 4, 2026Adjusted EBITDAFY2026$19.00M – $20.00MNew
Nov 4, 2026revenueFY2026$120.00M – $125.00MNew
Aug 10, 2026capexFY2026$8.00M – $10.00MNew
Aug 10, 2026Adjusted EBITDAFY2026$17.00M – $20.00MReaffirmed
Aug 10, 2026revenueFY2026$120.00M – $125.00MReaffirmed
May 6, 2026Adjusted EBITDAFY2026$17.00M – $20.00MReaffirmed
May 6, 2026revenueFY2026$120.00M – $125.00MNew
Mar 9, 2026Adjusted EBITDAFY2026$17.00M – $20.00MNew
Mar 9, 2026production volumesFY2026122 – 125New
Mar 9, 2026Additional revenue from other chemicals and productsFY202613% – 15%New
Mar 9, 2026PAC average selling price (“ASP”)FY2026$1 – $1New
Mar 9, 2026revenueFY2026$120.00M – $125.00MNew
Nov 5, 2025Capital expenditures forecastFY2025$8.00M – $12.00MNew
Aug 11, 2025Capital expendituresFY2025$8.00M – $12.00MReaffirmed
May 7, 2025Capital expenditures forecastFY2025$8.00M – $12.00MNew
Nov 7, 2024remaining to be spentQ4 FY2024$20.00M – $25.00MNew
Nov 7, 2024Capital expenditure forecastsFY2024$60.00M – $70.00MReaffirmed
Aug 12, 2024CapexFY2024$60.00M – $70.00MReaffirmed
May 8, 2024capex forecastFY2024$60.00M – $70.00MRaised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Arq filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. Results
  4. News
  5. Results
  6. Results
  7. Results
  8. Results
  9. News
  10. Results
  11. Results
  12. Results
  13. Update
  14. Results
  15. News

See a number that looks wrong?